Work

ITPKB is a Conserved Regulator of Natural Killer Cell Desensitization/education that Constrains Antitumor Immunity

Year: 2026

Type: preprint

Source: SSRN Electronic Journal

DOI: 10.2139/ssrn.7169781

Authors: Yeara Jo, Alexandros Karampatzakis, Seung Won Lee, Alice Peng, Zaina Ghouri, Monsserratt Moya, Elizabeth Andrews, Harrison Sudholz, Chenyu Zhang, Berna Bou Tayeh, Alejandro N. Medina, Jiucheng Ding, Robert A. Saxton, Ziyang Zhang, Yang Shi, Hideho Okada, David H. Raulet

Institutions: University of California, Berkeley, University of Oxford, Ludwig Cancer Research, University of California, San Francisco, Parker Institute for Cancer Immunotherapy, UCSF Helen Diller Family Comprehensive Cancer Center

Language: English

Topic: Immune Cell Function and Interaction

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Science Foundation, Cancer Research Institute, California Institute for Regenerative Medicine, Amgen, Cancer Research Coordinating Committee, National Institutes of Health, University of California, San Francisco, National Institute of Neurological Disorders and Stroke

Awards: G1152192941, Pacific Biosciences PacBio RS Single Molecule Real Time Sequencer, Graduate Research Fellowship Program (GRFP), G4975449653, G6774890067, G7489023513, Training the Next Generation of Biologists and Engineers for Regenerative Medicine, G9000103983, Tregulatory cell-mediated suppression of tumor elimination by NK cells and CD4 T cells

OpenAlex ID: W7170140397

Cites: 97

Cited by: 1

Related to: